Thyme (Thymus vulgaris / unspecified)
Evidence status
Limited evidence to recommend for any consumer outcome yet.
5 papers · 0 claims · 35 outcomes scored
Risk profile
Adverse events and known drug interactions
Safety events
respiratory distress severe
ataxia severe
lethargy severe
hemorrhagic foci severe
hepatotoxicity severe
carcinogenicity severe
polymorphonuclear cell infiltration moderate
hypersalivation moderate
Drug interactions
Aspirin moderate decreases effect
Warfarin moderate increases effect
other moderate increases concentration
Cisplatin moderate unknown
Sources
- 1. Comparative effect of thymus vulgaris and ibuprofen on primary dysmenorrhea: A triple-blind clinical study. (2014) ↑
- 2. Effect of thyme-ivy syrup on antiviral immune response in patients with mild COVID-19: a prospective, open-label, randomized pilot study. (2025) ↑
- 3. The effect of Zataria multiflora on respiratory symptoms, pulmonary functions, and oxidative stress parameters: a systematic review and meta-analysis. (2025) ↑
- 4. Effectiveness of thyme honey in the management of xerostomia in geriatric patients with end-stage renal disease: a randomized controlled clinical trial with a biochemical assessment. (2023) ↑
- 5. Effects of Zataria Multi-Flora, Shirazi thyme, on the Severity of Premenstrual Syndrome. (2013) ↑
Generated August 14, 2026